rHEALTH FVIII Kit Mentioned in Article on Consumer Diagnostics (IEEE Spectrum)

Emily Waltz, for IEEE Spectrum, writes about rHEALTH's first regulatory clearance and implications of the technology for developments in consumer-driven, biomedical diagnostics. Recently, rHEALTH  achieved CE marking of its Fluorogenic Factor VIII (FVIII) Test Kit for professional use and met the requirements of CD 98/79/EEC (the European IVD Directive). 

Read more at IEEE Spectrum: https://spectrum.ieee.org/the-human-os/biomedical/diagnostics/moving-blood-tests-from-the-lab-to-the-consumer